Actively Recruiting
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Led by The University of Texas Medical Branch, Galveston · Updated on 2026-01-09
15
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
CONDITIONS
Official Title
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 6518 years
- Diagnosed with aneurysmal subarachnoid hemorrhage, Hunt and Hess Grades 1-2
- Consent to study procedures and follow-up evaluations
You will not qualify if you...
- Known allergies to lidocaine or steroids
- Presence of arteriovenous malformations
- Presence of dural arteriovenous fistulas
- Other significant intracranial pathologies
- Hemodynamic instability preventing safe intervention
- Previous middle meningeal artery interventions
- Previous craniotomies or need for craniotomy
- Need for external ventricular drain
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Texas Medical Branch, Galveston
Galveston, Texas, United States, 77555-0158
Actively Recruiting
Research Team
M
Matias Costa
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here